Literature DB >> 20884718

Prophylaxis of invasive fungal diseases in patients with hematologic disorders.

Corrado Girmenia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20884718      PMCID： PMC2948086          DOI： 10.3324/haematol.2010.028878

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation.

Authors: 
Journal:  Cytotherapy       Date:  2001       Impact factor: 5.414

3.  Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Authors:  Corrado Girmenia; Giovanni Barosi; Franco Aversa; Andrea Bacigalupo; Tiziano Barbui; Donatella Baronciani; Alberto Bosi; Anna Candoni; Anna Locasciulli; Franco Locatelli; Francesco Menichetti; Maurizio Musso; Claudio Viscoli; Alessandro Rambaldi
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

4.  Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.

Authors:  K A Marr; K Seidel; M A Slavin; R A Bowden; H G Schoch; M E Flowers; L Corey; M Boeckh
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

5.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Authors:  J Maertens; O Marchetti; R Herbrecht; O A Cornely; U Flückiger; P Frêre; B Gachot; W J Heinz; C Lass-Flörl; P Ribaud; A Thiebaut; C Cordonnier
Journal:  Bone Marrow Transplant       Date:  2010-07-26       Impact factor: 5.483

6.  Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Authors:  Catherine Cordonnier; Montserrat Rovira; Johan Maertens; Eduardo Olavarria; Catherine Faucher; Karin Bilger; Arnaud Pigneux; Oliver A Cornely; Andrew J Ullmann; Rodrigo Martino Bofarull; Rafael de la Cámara; Maja Weisser; Effie Liakopoulou; Manuel Abecasis; Claus Peter Heussel; Marc Pineau; Per Ljungman; Hermann Einsele
Journal:  Haematologica       Date:  2010-07-15       Impact factor: 9.941

7.  Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

Authors:  Drew J Winston; Richard T Maziarz; Pranatharthi H Chandrasekar; Hillard M Lazarus; Mitchell Goldman; Jeffrey L Blumer; Gerhard J Leitz; Mary C Territo
Journal:  Ann Intern Med       Date:  2003-05-06       Impact factor: 25.391

8.  Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.

Authors:  Takahiro Fukuda; Michael Boeckh; Katherine A Guthrie; Debra K Mattson; Stephanie Owens; Anna Wald; Brenda M Sandmaier; Lawrence Corey; Rainer F Storb; Kieren A Marr
Journal:  Biol Blood Marrow Transplant       Date:  2004-07       Impact factor: 5.742

9.  Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants.

Authors:  Kieren A Marr; Fulvio Crippa; Wendy Leisenring; Maggie Hoyle; Michael Boeckh; S Arunmozhi Balajee; W Garrett Nichols; Benjamin Musher; Lawrence Corey
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

10.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079
View more
  2 in total

1.  Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.

Authors:  Catherine Cordonnier; Montserrat Rovira; Johan Maertens; Oliver A Cornely; Per Ljungman; Hermann Einsele
Journal:  Haematologica       Date:  2011-02       Impact factor: 9.941

2.  Invasive coinfection with Aspergillus and Mucor in a patient with acute myeloid leukemia.

Authors:  Rui Bergantim; Elisabete Rios; Fernanda Trigo; Jose Eduardo Guimarães
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.